• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR050502J
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/13/2019
Event Type  malfunction  
Event Description
The following was reported to gore: on (b)(6) 2019, the patient underwent treatment for a significantly calcified occlusion lesion in the left superficial femoral artery using two gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn) from the superficial femoral artery (sfa) to below knee (bk) bypass procedure.A 6mm x 5cm viabahn was placed first followed by a 5mm x 5cm viabahn.Upon removal of the 5mm x 5cm viabahn delivery catheter, strong resistance was encountered.However, the delivery catheter was removed from the patient.Then a smart stent was placed within the two viabahns.After the treatment of the occlusion lesion in the left sfa, the sfa-bk bypass procedure was performed.During the bypass procedure, it was observed that a separated tip/portion of the delivery catheter remained in the left sfa.The length of the separated tip was about 5cm.The tip was immediately retracted from the patient.The bypass procedure was completed without further issue.The patient tolerated the procedure.It was reported that pre-ballooning was not performed.Reportedly, the tip of the delivery catheter may have been caught on the sheath tip or caught within the significantly calcified occlusion lesion and may have become separated during removal of the delivery catheter.It was stated that the second device was identified as the device with the delivery catheter tip separation.
 
Manufacturer Narrative
Results code 1: 213: a review of the manufacturing records for the device verified the lot met pre-release specifications.Results code 2: 213: the engineering evaluation stated the following: the distal shaft, upon which the endoprosthesis was mounted, and the distal tip was returned.Approximately 5 cm of the distal shaft was returned with a kink approximately 2 cm from the transition end of the distal shaft.The stainless steel braid in the distal shaft on the transition end appeared to be frayed and broken.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Manufacturer Narrative
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #20746523.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
Additional manufacturer narrative: a1.- patient identifier.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9537153
MDR Text Key195951433
Report Number2017233-2020-00001
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 07/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/01/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/12/2022
Device Catalogue NumberJHJR050502J
Device Lot Number20746523
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/23/2019
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-